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Excess direct medical costs of severe obesity by
socioeconomic status in German adults
Direkte medizinische Exzesskosten der schweren Adipositas nach
sozio-ökonomischem Status bei Erwachsenen in Deutschland
Abstract
Objective: Excess direct medical costs of severe obesity are by far
higher than of moderate obesity. At the same time, severely obese
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higherexcesscoststhanthosewithhigherSES,e.g.duetomorecomor-
KORA Study Group bidities. This study compares excess costs of severe obesity among
German adults across different SES groups.
Methods: In a subsample (N=947) of the KORA-Survey S4 1999/2001
(a cross-sectional health survey in the Augsburg region, Germany; age
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Hannover, Germany group: 25–74 years), visits to physicians, inpatient days in hospital,
and received and purchased medication were assessed via computer-
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assisted telephone interviews (CATI) over half a year. Body mass index
(BMIinkg/m²)wasmeasuredanthropometrically.SESwasdetermined
Environmental Health,
via reports of education, income, and occupational status from com- InstituteofHealthEconomics
puter-assistedpersonalinterviews(CAPI)(usedbothassingleindicators, and Health Care
andasindexedbytheHelmertalgorithm);duetosmallsubsamplesizes Management, Neuherberg,
Germany all were median-split. Data of respondents in normal weight (18.5 ≤
BMI < 25), preobese (25 ≤ BMI < 30), moderately (class 1:30 ≤ BMI
< 35) and severely obese (classes 2–3: BMI ≥ 35) range were analysed
by generalized linear models with mixed poisson-gamma (Tweedie)
distributions. Physician visits and inpatient days were valuated as re-
commended by the Working Group Methods in Health Economic Evalu-
ation(AGMEG),anddrugswerevaluatedbyactualcosts.Sex,age,kind
ofsicknessfund(statutory/private)andplaceofresidence(urban/rural)
were adjusted for, and comorbidities were considered by the Physical
Functional Comorbidity Index (PFCI).
Results:Excesscostsofsevereobesitywerehigherinrespondentswith
high SES, regardless of the SES indicator used. For instance, annual
excess costs were almost three times higher in those with an above-
median SES-Index as compared with those with a median or lower SES-
Index (plus € 2,966 vs. plus € 1,012; contrast significant at p<.001).
Mediation of excess costs of severe obesity by physical comorbidities
pertained to the low SES-Index and the low occupational status groups:
differences in costs between severe obesity and normal weight were
still positive, but statistically insignificant, in the lower status groups
afteradjustingforthePFCI,butstillpositiveandsignificantgivenhigher
SES. For example, severe obesity’s excess costs were € 2,406 after
PFCI-adjustment in the high SES-Index group (p<.001), but € 539 in
thelowerstatusgroup(p=.17).Atthesametime,physicalcomorbidities
as defined by the PCFI increased with BMI and decreased with SES,
however the factors BMI and SES did not significantly interact in this
context.
Conclusions:Toourknowledge,thisisthefirststudytoshowinGermany
that excess direct medical costs of severe obesity are not distributed
equitablyacrossdifferentSESgroups,donotreflectcomorbiditystatus,
and are significantly higher in those with high SES than in those with
lower SES. Thus, allocation of health care resources spent on severely
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Zusammenfassung
Zielsetzung: Die direkten medizinischen Exzesskosten der schweren
AdipositassinddeutlichhöheralsdiedermoderatenAdipositas.Zugleich
istzuerwarten,dass(schwer)adipöseErwachsenemitniedrigemsozio-
ökonomischenStatus(SES)höhereExzesskostenaufweisenalssolche
mit höherem SES, z. B. aufgrund höherer Komorbiditäten. Diese Studie
vergleichtdieExzesskostender(schweren)AdipositasbeiErwachsenen
in verschiedenen SES-Gruppen.
Methodik: In einer Teilstichprobe (N=947) des KORA-Survey S4
1999/2001 (ein querschnittlicher Gesundheitssurvey in der Region
Augsburg; Altersgruppe: 25–74 Jahre) wurden Arztkontakte, Medika-
mentenkäufe und -erhalte sowie stationäre Krankenhaustage über ein
halbes Jahr via computergestützte telefonische Interviews (CATI) erho-
ben. Der Body Mass Index (BMI in kg/m²) wurde anthropometrisch ge-
messen. Der SES wurde durch Angaben zu Bildung, Einkommen und
Berufstatus aus computergestützten persönlichen Interviews (CAPI)
bestimmt(siegingensowohlalsEinzelindikatorenalsauchalsHelmert-
Index in die Analysen ein); alle wurden wegen geringer Teilstichproben-
größen medianhalbiert. Die Daten von Teilnehmern mit Normalgewicht
(18,5 ≤ BMI < 25), Präadipositas (25 ≤ BMI < 30), moderater (Grad
1:30 ≤ BMI < 35) und schwerer Adipositas (Grade 2–3: BMI ≥ 35)
wurden mittels allgemeiner linearer Modelle mit gemischten Poission-
Gamma-(Tweedie-)Verteilungenanalysiert.ArztkontakteundKranken-
haustage wurden gemäß dem Vorschlag der Arbeitsgruppe Methoden
der gesundheitsökonomischen Evaluation (AG MEG) bewertet, und
Medikamente mit den tatsächlichen Kosten. Für Geschlecht, Alter,
Krankenkasse (GKV/PKV) und Wohnort (Stadt/Land) wurde adjustiert,
und Komorbiditäten mittels des Physical Functional Comorbidity Index
(PFCI) berücksichtigt.
Ergebnisse:DieExzesskostenderschwerenAdipositaswareninGruppen
mit hohem SES höher, unabhängig vom verwendeten SES-Indikator. So
waren diese jährlichen Exzesskosten in der Gruppe mit einem SES-In-
dexwert überhalb des Medians um den Faktor drei gegenüber der
GruppemiteinemmedianenoderkleinerenSES-Indexwerterhöht(plus
€ 2.966 vs. plus € 1.012; signifikanter Kontrast: p<.001). Die Vermitt-
lung der Exzesskosten der schweren Adipositas durch körperliche Ko-
morbiditäten beschränkte sich auf niedrigen SES-Index und Berufssta-
tus.DabeiwarendieKostendifferenzialezwischenschwererAdipositas
und Normalgewicht nach Adjustierung für den PFCI bei niedrigem SES
zwar weiterhin positiv aber statistisch nicht mehr signifikant, hingegen
warensiebeihöheremSESweiterhinpositivundsignifikant.Hierbetru-
gen die Exzesskosten der schweren Adipositas € 2.406 in der hohen
SES-Indexgruppe (p<.001), jedoch € 539 in der unteren Statusgruppe
(p=.17). Gleichzeitig waren körperliche Komorbiditäten im Sinne des
PFCI positiv mit dem BMI und negativ mit dem SES assoziiert, wobei
die Faktoren BMI und SES allerdings nicht signifikant interagierten.
Fazit: Die vorliegende Studie ist unseres Wissens die erste, die in
Deutschlandzeigt,dassdieExzesskostenderschwerenAdipositasüber
unterschiedlichenSES-Gruppenungleichverteiltsind,nichtdenKomor-
biditätsstatusreflektieren,undinhohenSES-Gruppensignifikanthöher
ausfallen als in niedrigeren SES-Gruppen. Es besteht offenbar Bedarf
an einer besseren Allokation der Ressourcen gesundheitsbezogener
Versorgung, die für (schwer) adipöse Erwachsene ausgegeben werden,
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Introduction
Compared to normal weight, obesity has been shown to
beassociatedwithexcesshealthcarecostsamongadults
in virtually all relevant studies (for reviews since 2005,
see [1], [2], [3], [4], [5], [6]). Most pronouncedly, costs
tend to increase with severe obesity, i. e. obesity classes
II and III (for obesity classification, see [7]). Among 54-
to 69-year-olds in the US, for instance, these classes
result in 50% and 100% higher per-capita costs above
normal weight, respectively, which compares to 25% for
moderate obesity (i. e. class I) [8]. In another study on
US adults aged 18 years or older, costs in class III were
81%, 65% and 47% greater than in normal weight, pre-
obesity, and obesity class I, respectively [9]. Comparable
data exists for Germany, where annual per-capita costs
among adults aged 25 to 74 years have been estimated
at€2,572.19inthoseseverelyobeseversus€1,080.59
in those moderately obese, comparing to € 847.60 in the
normal weight group [10]. These variations in excess
costs across different levels of obesity are especially rel-
evant since the prevalence of severe obesity is growing
at a faster rate than moderate obesity, including the US
[11], [12]. In Germany, it can be estimated from national
health monitoring data that the prevalence of moderate
obesity was 1.3 times higher in 2002 than in 1985
(16.5% vs. 13.2%), whereas that of severe obesity more
than doubled (6.5 vs. 3%) [13].
While it may not be surprising that severe obesity results
in markedly higher excess costs both because it repre-
sentsamoreseriousdisease-relatedhealthproblemthan
moderate obesity, and (multiple) concomitant medical
conditions – i.e., (multi-)co¬morbidity – may be more
likely, it is largely unknown whether these excess costs
differacrossdifferentsocioeconomicstatus(SES)groups.
Apart from the well-known fact that obesity generally has
a higher prevalence in lower SES groups to begin with
[14], [15], it could be expected that socioeconomically
disadvantated severely obese individuals have more co-
morbidities than higher SES groups, which under condi-
tions of equitable health care should result in higher
utilization of care. Conversely, if comorbidity is compar-
able, differences in costs for severely obese compared
to normal weight patients (i.e., the excess costs attribut-
able to this condition [16]) should be similar across dif-
ferent SES groups. Finally, the mediating role of comor-
bidities for excess costs should be independent of SES:
if severely obese persons utilize health care more that
those in normal weight range because they have comor-
bidities, this should – again, given equity – hold for both
low and high SES groups. Against this background, this
paper analyses excess direct medical annual per-capita
costs of different forms of overweight (with special em-
phasis on severe obesity) within different SES groups in
anadultpopulationinGermany,andpossiblemediations
of existing differences by physical comorbidity.
Methods
Population and sampling
Collection of data was conducted within the KORA- (Co-
operative Health Research in the Region of Augsburg-)
Survey S4 1999/2000, a representative cross-sectional
healthsurveyinthecityofAugsburgandthetwoadjacent
administrativedistricts,Germany(forgeneralinformation
on the KORA research platform, see [17]). Approval of
the responsible ethics committee (Bavarian Medical As-
sociation, Munich) was secured. The target population
consisted of all German residents of the region born
between July 1, 1925 and June 30, 1975. A sample of
N=6,640 was drawn in a two-stage sampling procedure.
In addition to Augsburg city, 16 out of 70 communities
from the adjacent counties were chosen by cluster
sampling with probability proportional to size. Using
public registry office listings, stratified random sampling
wasperformedwithineachcommunity,yieldingtenstrata
of equal size according to gender and age. Selection
withineachstratumusedthefunctionRANUNIinSAS8.1
forWindows.FieldworklastedfromOctober1999toApril
2001. The response rate was 67%, comparing well to
othersurveys[18].Anon-respondersurveyviatelephone,
inwhich49%participated,revealedthatnon-responders
moreoftenhadlowereducation(uptosecondarygeneral
school: 65% vs. 54%) and fair or poor self-rated health
(28%vs.21%),weremoreoftenunmarried(34%vs.29%)
and smokers (29% vs. 26%), and more frequently repor-
ted physician contact in the last four weeks (46% vs.
38%), myocardial infarction (6% vs. 3%), and diabetes
(7%vs.4%)[18].Ultimately,N=4,261participatedinthis
“main part” of the survey.
Of these, a random sample of N=1,186 with 30 nearly
balanced strata by gender, age, and body mass index
(BMI; see below, Measures) was drawn for a three-wave
computer-assistedtelephoneinterview-(CATI-)partofthe
survey after two, four, and six months. Ultimately, N=947
participated in all three waves (response rate: 80%).
FieldworklastedfromOctober1999toAugust2001,and
averaged over seven and a half months for any parti-
cipant. Non-responders were more often men (23% vs.
17%), from the lowest socioeconomic stratum (23% vs.
19%), unmarried (27% vs. 17%), and smokers (29% vs.
17%), but did not differ in health care utilization or mor-
bidity.N=5withaBMI<18.5wereexcludedfromanalysis
for reasons of cell count, and possible underweight-spe-
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for the present analysis.
Measures
Obesity
Bodyweightandheightwereassessedanthropometrically
in the survey’s physical examination part following inter-
national standards [17], [19]. Participants stood without
shoes and heavy outer garments [20], and steelyards
(SECA709)withintegratedscales(SECA221)wereused.
Calibrationofinstrumentswasensuredbyweeklyordaily
inspections using standard weights or resistors. Body
mass was indexed by dividing weight in kg by (height in
m)². Groups were defined following WHO classifications
[7]: normal weight (18.5 ≤ BMI < 25), preobesity (25 ≤
BMI < 30), obese class I (30 ≤ BMI < 35), obesity class
II (35 ≤ BMI < 40), and obesity class III (BMI ≥ 40). For
reasons of cell count (especially regarding class III)
classes II and III were pooled. In line with WHO nomen-
clature [7], class I is referred to as “moderate obesity”
and classes II–III as “severe obesity”.
Direct medical costs
Utilizationofcarewasassessedviaself-reportinthethree
CATI-waves. In each wave, items for physician utilization
read as follows: “In the last 8 weeks, did you consult any
physician?”,(ifyes)“Howoftendidyouconsultaphysician
inthelast8weeks?”,and(foreveryconsultation)“Which
medical field did this physican belong to: general practi-
tioner, internal specialist, (for women) gynaecologist,
otorhinolaryngologist, dermatologist, dentist, or other?”.
Foreachfield,theconsultationsweresummedupacross
the three 8-week-periods, excluding dentists. Likewise,
the number of inpatient days were estimated, using the
following items in each CATI-wave:“„In the last 8 weeks,
have you been hospitalised at all?“ and (if yes) “In sum,
how many days or weeks have you been hospitalised in
the last 8 weeks?“. Both physician consultations and in-
patient days were valuated according to the recommen-
dationsoftheWorkingGroup“MethodsinHealthEconom-
ic Evaluation” (AG MEG) of the German Society of Social
MedicineandPrevention[21],andextrapolatedto1year.
In contrast, costs for medications were determined as
follows. In each CATI-wave, the following screening
question was asked: “Have you received or purchased
medications(withorwithoutprescription)inthelastweek,
irrespectiveoftakingorapplyingitinthisperiodoftime?”.
If“yes”,respectivemedicationswereassessedusingthe
IDOM software, an instrument for collection and pro-
cessing of medication data in computer-assisted inter-
views, which valuates these data with the prices in the
drug classification by the German Drug Index of the Re-
search Institute of the Local Sickness Funds (WIdO) [22].
Finally, total per-capita costs were defined by summing
up costs for out- and inpatient use and medications per
respondent.Theidenticalmethodhasalreadybeenused
in a previous publication [10]. It has to be stressed that
the monetary valuation not only of drugs, but of ambula-
tory medical services and hospital care as well, is based
on identical unit costs across both public and private
health insurance (which is not true in terms of prices).
Therefore, cost differentials between subsamples of our
study population cannot result from differences in the
public-private insurance mix between the subsamples;
instead, they always reflect differences in the volume of
health care utilization.
Physical comorbidity
Physical comorbidity was assessed via the “Physical
Functional Comorbidity Index” (PFCI) [23], [24], [25],
which is based on the Functional Comorbidity Index (FCI)
[26]. Basically, given the aim of the present and the
earlier studies, it was crucial to assess individual health
status of respondents on both a broad and valid basis.
To this end, respondents’ medical histories were drawn
upon,whichhadbeenassessedbyself-reportforthelast
12 months via the computer-aided personal interviewing
(CAPI)partofthesurvey.Methodologically,thesemedical
histories build on the MONICA (Multinational Monitoring
of Trends and Determinants in Cardiovascular Disease)
Augsburg protocol [17], [19]. Specifically, the selection
of the FCI as basis for indexing comorbidities rested on
two rationales. First, an alternative morbidity index em-
ployed in an earlier KORA-study [27] only represented a
dichotomous index (i.e., any vs. no morbidity). Second,
theFCIrelatesbetterthanotherindicesformultimorbidity
(e.g. the Charlson index [28]) to the medical histories’
assessment in the KORA studies. Nevertheless, unlike
the FCI, the PFCI does not include neurological diseases
(such as multiple sclerosis or Parkinson's), depression,
anxiety or panic disorders, visual impairments, and
hearing impairments, since they were not available to us
(hence, for conceptual precision, the designation PFCI),
nor obesity (as it is the focal explanatory variable of the
present analysis). All told, the PFCI takes into account
the following diseases: myocardial infarction, cerebral
infarction, diabetes, angina pectoris, arterial obstructive
disease, cardiac insufficiency, arthrosis, attrition of ver-
tebral column and/or intervertebral discs, osteoporosis,
bronchialasthma,gastrointestinaldiseases,andchronic
obstructive pulmonary disease. This reduction from 18
to 12 conditions has been judged by the FCI's developer
as rendering an index with acceptable validity (Dianne
Groll,personalcommunication,April01,2006).Following
FCI recommendations [25], the unweighted form of the
index is used in the following analysis.
Socioeconomic status (SES)
Education, income and occupational status were as-
sessed following national recommendations [29] and –
besides being used as single indicators – summarized
to a SES-index using the algorithm proposed by Helmert
[30].Variablesaredefinedasfollows:highesteducational
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to number and age of household members, with weights
of 1 for the head of the household, 0.5 for household
members aged 6 years or younger, 0.65 for those
between 7 and 14 years, 0.9 for those between 15 to
17, and 0.8 for those 18 or older), current or former em-
ployment status, and current or former occupational
status (own or of partner). The SES-Index has a maximal
range of 2–27 points and allows the following classifica-
tion: lower social class (2–8 points), lower middle class
(9–11points),intermediatemiddleclass(12–14points),
uppermiddleclass(15–18points),anduppersocialclass
(19–27 points). Yet, for the present analyses a median-
split at 13 points had to be used due to small subsample
sizes, despite taking losses in theoretical and statistical
powerimpliedbymedian-splitting[31].Forexample,there
areonlyN=10respondentsintheuppersocialclasswith
severe obesity. This seriously jeopardizes the robustness
of the mean costs estimate since even if assuming a
medium effect size (e.g. 0.5), a subsample size of N=27
is necessary to determine whether the population mean
equals some specified value with a test power of 0.8 (at
p=.05).
Covariates
Sex, age and place of residence (urban vs. rural) were
knownfromthesamplingprocedure,whiletypeofhealth
insurance (statutory vs. private) was assessed by self-re-
port.
Statistical modelling
Following descriptive analysis, annual per-capita costs
were analysed by generalized linear modelling as recom-
mendedincostdataanalysismethodology[32].Specific-
ally, mixed poisson-gamma models were conducted
(family=tweedie, link=log) based on the following ra-
tionales. First, the skewed distribution of the costs data
was taken into account by the log link [33], and the in-
creasing variability of costs with increasing BMI-values
by dispersion modelling [34]. Second, this approach
providespotentiallymorerobustestimatorsthanalterna-
tive models such as ordinary least squares (OLS) with
normalerrors,orOLSforthelognormal[33][,[35].Third,
since mean costs for different subgroups based on all
cases (i. e. including participants with no costs) is the
primary interest (not utilization per se), a single-equation
generalized linear model (GLM) was sought which allows
for a non-zero probability of zero values [36], [37]. This
is why a GLM with a mixed poisson-gamma (Tweedie)
distribution [34], [38], [39], [40] was selected. This has
beenshowntocompetewellwithtwopartbinary/gamma
models [38], and by involving only one equation it avoids
theproblemofposthocadjustmentforheteroscedasticity
in order to remove biases in predicted means for the en-
tire population and relevant subgroups [37]. For all ana-
lyses, SPSS Statistics 17.0 was used.
Finally, the aims of the present analysis were pursued in
these GLM as follows. Following [16], any costs attribut-
able to a given condition were defined as the difference
between the costs in those affected by the condition (in
thepresentcase:preobesity,moderateobesityorsevere
obesity) and the costs in those without the condition (i.e.
the baseline costs, here: the normal weight group). Ac-
cordingly, the analytical design implemented in GLM is
as follows:
• Basically,ineachGLMtwofactorswerespecified:BMI
as the four groups defined above, and one of the four
SES indicators, which are SES-Index (labeled SES),
education(EDU),income(INC),andoccupationalstatus
(OCC).Boththemaineffectsandtheinteractionofthe
BMI- and the SES-factor were considered. Besides,
sex,age,healthinsurancetype,andplaceofresidence
were entered as covariates.
• In each model – besides the two main effects, their
interaction, and the four covariates – the following
contrasts were tested in line with the excess costs
approach described above: “preobese vs. normal
weight”, “moderately obese vs. normal weight”, and
“severely obese vs. normal weight”. Specifically, each
contrast was tested
(a) overall, i. e. regardless of SES, EDU, INC, or OCC,
(b) in regard to its interaction with the socioeconomic
factor(e.g.“contrastBYSES”)toindicatewhetherthe
excesscostsindicatedinthecontrastdifferedbetween
each higher and lower socioeconomic group, and
(c) within both the high and the low socioeconomic
group (e. g. “contrast WITHIN SES-high” and “contrast
WITHIN SES-low“) in order to determine if significant
excess costs hold for both groups.
• Subsequently, the procedure described so far was re-
peated, now including the PFCI as a covariate in order
to clarify whether existing excess costs are mediated
by comorbidities [41].
• Finally,analyseswereconductedondifferencesinthe
PFCIacrossBMI-andSES-subgroups(viaGLMproced-
ures corresponding to those described) in order to
clarify if any differences in the BMI-PFCI-association
by SES may determine costs differences.
Results
Table 1 describes the sample of N=942 participants by
cross-tabulating the BMI-factor with all other variables.
Whileoverall,sex,ageandplaceofresidenceareequally
distributedsincetheyservedasstratificationdimensions
in the sampling procedure (besides BMI), a difference
pertains to the fact that in the severely obese group, wo-
men represent a two-thirds majority. Furthermore, while
only small differences are found for type of health insur-
ance,respondentsfromlowersocioeconomicgroupsare
morestronglyrepresentedinobesevs.nonobesegroups.
This holds both for the SES-Index as well as for the single
indicators education, income, and occupational status.
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Table 2 shows the distribution of annual direct medical
costs for different subgroups. To begin with, the first
column shows that overall a minority had no costs
(14.7%), and even among the youngest subgroup, a
similar assertion holds (25.9%). Regarding costs, overall
€1,043.03per-capitawerefoundonaverage(seesecond
column). Outlier-trimming by excluding eight participants
with costs exceeding € 20,450 reduced mean costs to
€ 780.99 (the cut-point of € 20,450 was chosen both
because it lies in the interval characterized by an excep-
tionally large costs gap between a pair of adjoining parti-
cipants – specifically, € 15,894.40 and € 22,818.98 –,
and because it has been used before to define high util-
izers in German health care, e.g. in risk adjustment
schemes). However, excess cost analyses regarding
obesity were not principally affected in terms of results.
For instance, the mean costs of moderate and severe
obesity were about 1.3 and 3.3 times higher than those
of normal weight, respectively, for the sample including
the outliers (€ 2,713.32 and € 1,110.52 vs. € 828.66,
respectively). Without the outliers, these factors are 1.4
and 2.7 (€ 1,629.81 and € 865.77 vs. € 600.91), and
thusareapproximatelyequivalent.Alongtheselines,and
because high utilizers eventually are part of health care
as well as others, and often critical to health care costs,
all following analyses include these eight outliers.
Meancostdifferencesacrossageandcomorbiditygroups
are as expected, with highest costs in the 65- to 75-year-
olds (€ 1,407.21) and especially those with two or more
comorbidities(€1,990.60).Smallerdifferencesarefound
forwomenvs.men,statutoryvs.privatehealthinsurance,
and rural vs. urban place of residence. Finally, slightly
higher costs are seen in lower SES groups, regardless of
SESindicator(indexorsingle),duetoslightlyhigherrates
of those with costs exceeding € 20,450 (as indicated by
the mean costs when excluding the latter cases).
Table3andFigure1showthemainresultsofthepresent
analysis. Table 3 shows the results from ten GLM models
adjusted for sex, age, health insurance, and place of
residence: two models with the BMI-factor only, without
andwithadjustmentforthePFCI(I.(a)andI.(b)),andeight
models with the BMI-factor and one of the four SES-
factors, respectively, which again either do not (II.(a),
III.(a), IV.(a) and V.(a)) or do adjust for the PFCI (II.(b),
III.(b), IV.(b) and V.(b)). To begin with, the BMI-main effect
is significant in both “BMI-factor only”-models I.(a) and
I.(b)(p<.001).Specifically,inbothcasestheonlysignific-
ant contrast to normal weight is seen for severe obesity.
Numerically, these excess costs are estimated at €
1,873.36 when not adjusting for PFCI and at € 1,339.38
after including the PFCI. These results basically replicate
those reported previously [10] but now rest upon mixed
poisson-gamma GLM instead of OLS and binary/gamma
models.
Morespecificallyrelatedtotheresearchquestionsofthe
present paper, models II.(a) and II.(b) which include the
factorsBMIandSES-Indexcanbesummarizedasfollows.
First, without adjusting for the PFCI, not the SES main
effectbutitsinteractionwiththeBMI-factorissignificant.
As the interactions of the three contrasts (preobesity,
moderate obesity, and severe obesity vs. normal weight,
respectively) indicate, all three cost differentials vary
significantly across the two SES groups. Concerning
severe obesity (i.e. the only category of overweight which
had shown significant excess costs in model I.(a)), it is
associated with higher excess costs in the higher SES-
group (€ 2,965.83) than in the lower (€ 1,011.99). As
shown in Figure 1.II.(a), upper graph, these differentials
translate to mean costs of € 2,018 in the severely obese
low SES-group (vs. € 1,006 in the respective normal
weight group), and € 3,607 in the severely obese high
SES-group (vs. € 641). After adjusting for the PFCI in
model II.(b), two changes occur. On one hand, the SES-
maineffectbecomessignificantinthattheoverallestim-
ated difference between high vs. low SES changes from
€ 127.04 (€ 1,167.42 – € 1,040.38) to € 298.40
(€ 1,161.95 – € 863.55) (not shown in the table). Closer
inspection of this effect reveals that this is largely due to
the fact that the estimated costs of moderate obesity in
the low-SES group are reduced by the PFCI in this model
(from € 944 to € 798; see Figures 1.II.(a) and 1.II.(b)).
Finally, excess costs of severe obesity are mediated by
the PFCI in the lower but not in the higher SES-group.
While in the latter these excess costs are still highly sig-
nificant (€ 2,406.33, p<.001), they are largely reduced
in those with lower SES (€ 538.62, p=.170; see also
Figure 1.II.(b)).
Regarding the three single indicators of socioeconomic
position, results are largely equivalent to those for the
indexamongthemodelswithnoadjustmentforthePFCI.
Thisincludesthatregardlessoftheindicatorused,excess
costs of severe obesity are found both in the low and the
high status groups, and are significantly higher in the
groups with higher social status (especially in the case
of single indicator “education”).
AdjustmentforthePCFIrendersmoredifferentialresults.
While excess costs of moderate and severe obesity are
still higher in groups with higher socioeconomic position,
theonlycaseinwhichcomorbiditiessignificantlymediate
the excess costs of severe obesity in the lower status
group (i.e. like in the model with the SES-Index) is low
occupational status, i. e. in those having foreman status
or lower. Here, this excess cost estimate is reduced to
€ 752.12 (p=.072, from € 1,373.68, p=.005), while the
respective mean differences both for below-median in-
come and secondary general school or lower remain sig-
nificant (Table 3). As Figure 1.V.(b) shows, the severely
obesegroupwithlowoccupationalstatushasPFCI-adjus-
ted estimated mean costs of € 1,677 (vs. € 925 in the
normalweightgroup),whiletheseare€2,528(vs.€673)
in the higher occupational status group.
Figure 2 summarizes the key results regarding severe
obesity. As Figure 2(a) visualizes, without adjustment for
comorbidities there are significant excess costs in all
statusgroups,andtheyaresignificantlyhigherinthehigh
vs. low status groups. This pattern is most pronounced
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obesityinthosewithahighSES-indexandhigheducation
amount to € 2,965.83 and € 3,120.87, and compare to
€ 1,011.99 and € 1,151.07 in those with lower status,
respectively (differences between high and low status
group significant at p<.001 and p=.001, respectively).
As Figure 2(b) shows, adjustment for the PFCI renders
decreased and consistently significant excess costs in
all groups but those with a low SES-Index (€ 538.62) and
a low occupational status (€ 752.12). In other words,
physicalcomorbiditiessignificantlymediateexcesscosts
ofsevereobesity–ifatall–inlowersocialstatusgroups.
Finally,toexplorethepossibilitythatthecostdifferentials
described so far reflect differences in the association
between BMI and PFCI by SES, a GLM was run on differ-
ences in the PFCI across BMI- and SES-subgroups (as a
PFCI validation analysis in the KORA S4 main survey).
Unexpectedly, the BMI by SES-subgroups with high costs
did not show correspondingly high values on the PFCI. By
way of example, while main effects of the factors BMI
and SES-Index were significant (Wald χ²=46.83 and
27.61, respectively; p<.001) and indicated that comor-
bidities increased with high BMI and low SES, there was
no interaction between these two factors (Wald χ²=0.62;
p=.891). Thus, no evidence was found that the excess
burdens of disease in the preobese, moderately obese
andseverelyobesegroupsaremorepronouncedinthose
with high SES than those with lower SES (or, for that
matter, vice versa).
Discussion
Drawingonearlierpublisheddatawhichshowedthatthe
excess direct medical per-capita costs of obesity in Ger-
manyarebyandlargerestrictedtosevere(vs.moderate)
obesity [10], the present analyses reveal two addenda
to this general finding. First, the excess costs of severe
obesity are more pronounced in individuals with compar-
ably high SES, regardless of which SES indicator is used
(SES-IndexbyHelmert,education,income,oroccupational
status). For instance, the excess costs of severe obesity
are almost three times as high in those with an above-
median value on the SES-Index as compared to those
withmedianorlowerSES,withsimilarassertionsholding
for education and income. In the case of occupational
status, excess costs are roughly twofold in the higher
statusgroup.Second,mediationofexcesscostsofsevere
obesity by physical comorbidity only pertains to the lower
SES groups. Specifically, in the cases of the SES-Index
andoccupationalstatus,thedifferenceincostsbetween
severe obesity and normal weight is still positive but in-
significant in the lower status group after adjusting for
the PFCI. In contrast, it is positive and still significant in
the higher status group. Conversely, excess costs of
severeobesityaresignificantinbothlowandhigheduca-
tionandincomegroupsbothbeforeandafteradjustment
for the PCFI, which indicates that there is no mediation
bythePFCI.Numerically,excesscostsestimatesofsevere
obesity are almost halved by PFCI-adjustment in the
groups defined by low SES-Index and low occupational
status (reductions of 47% and 45%, respectively), while
downsized by only about one fifth (19% and 18%) in the
high status groups. Regarding education, the reduction
in the lower status groups is higher as well, however by
a clearly smaller margin (31% vs. 27%). Regarding in-
come, we found a 17% reduction in the low vs. a 35% in
the higher status group.
Several limitations of this study have to be considered.
First, the study sample only includes individuals of Ger-
man nationality living in the city and region of Augsburg.
Second, the KORA-Survey S4 had a nonresponse rate of
33%.Whilethismakesextrapolationstothetotalpopula-
tion difficult, there are no indications that it biases cost
differentials between the overweight groups and the
normal weight reference group. Third, the study only in-
cludes about two-thirds of the total health care costs
spectrum, i.e. outpatient care (general practitioners and
medicalspecialists),medications,andinpatientcare.The
exclusion of, most importantly, rehabilitative care and
medical aids and remedies, but also of complementary
and alternative services (for which data were not avail-
able)impliesatendencytounderestimateabsolutecosts
differentials between BMI-groups; whether this also ap-
plies to relative differentials as well is difficult to judge.
Also, it has to be noted that actual costs were known for
medications only, while for out- and inpatient services,
standard costs were used. Here, especially the use of
nationwide averages of daily hospital rate does imply
some imprecision, but there seems to be no obvious
tendency to under- or overestimate mean cost or costs
differentials.Fourth,thestudyiscross-sectional,andthus
does not allow causal conclusions. Nevertheless, since
the PCFI was included in the present analysis, so at least
physical comorbidities were available and analysed as a
mediator.
Fifth,duetosubsamplesizelimitations,stratificationover
and beyond the BMI x SES-grouping was possible neither
forsex,age,statutoryvs.privatetypeofhealthinsurance,
norurbanvs.ruralplaceofresidence(i.e.,thecovariates
in the present analyses). While this is not uncommon in
costofillnessstudiesinthecontextofobesity[9],further
studies should provide more indepth scrutiny of sub-
groups.Inthepresentcontext,ithastosufficetosaythat
results are robust against excluding the privately insured
participants (which may be of special interest given cur-
rent two-class medicine discussions in Germany). That
is, when looking only at those participants from statutory
sickness funds, the interactions both of the factors BMI
and the SES-Index, and the “severe obesity vs. normal
weight”-contrast with the SES-factor, were significant
(Wald χ²=26.19 and 16.87, respectively; p<.001), and
the PFCI mediated the excess costs of severe obesity in
those with low SES (mean difference after adjustment:
€ 556,43, p=.206) but not those with high SES
(€ 2.831,88, p<.001). Also, the excess costs of severe
obesity were on the same level as in the analysis which
included the privately insured.
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for dichotomizations of SES-indicators, thus reducing
analytical sensitivity to social gradients and absolute
deprivation.However,contrastingtwoSES-groupsdefined
bymediansplitsisstatisticallyconservative,i.e.differen-
tiating between more groups would probably more easily
detect cost differentials.
Finally,whiletheassessmentofcomorbiditiesbythePFCI
usedarecognizedinstrument[23],[24],[25],itdoesnot
include all possible physical (co-)morbidities. This is why
we recalculated the main GLM with the physical health
summary measure of the SF-12 [42] instead the PFCI.
This rendered comparable results: the interactions both
of the factors BMI and the SES-Index, and the “severe
obesity vs. normal weight”-contrast with the SES-factor,
weresignificant(Waldχ²=26.41and19.36,respectively;
p<.001), and poor subjective physical health mediated
the excess costs of severe obesity in those with low SES
(mean difference after adjustment: € 429,23, p=.339)
butnotthosewithhighSES(€2.370,59,p<.001).Against
this background, the role of physical comorbidity for the
excess costs of severe obesity seems to be fairly robust.
In contrast, no such assertion is possible regarding
mental comorbidities since the PFCI does not include
these, and since the SF-12 mental health summary
measure has been shown to be associated neither with
preobesity nor obesity in this population [43].
With these limitations in mind, results can be read as
follows.Tobeginwith,thesignificantlyhigherexcesscosts
of moderate and especially severe obesity in all groups
with high vs. low SES raise the question how health care
in both groups is related to need. Because the pattern of
costsdoesnotparalleltheburdenofcomorbiditiesinthe
different subgroups, which shows increasing comorbid-
ities associated with increasing BMI and higher SES, but
no interaction, both underuse in low-SES groups and
overuse by high-SES groups are possible explanations.
Becauseinformationontheactualreasonsofhealthcare
use were not available in the present data (and mental
comorbidities not covered by the PCFI), compelling argu-
ments for or against either one interpretation unfortu-
natelyarenotviable.Possibilitiesarethatseverelyobese
high-SES patients may be more aware of the condition
and assertive in negotiating the quality and quantity of
the health care they receive, or offered more services. In
addition, it is interesting that in the only other study we
could find on SES-differences in excess costs of obesity,
namely from Taiwan [44], excess costs of obesity have
been found only in low, not high SES groups (as defined
by education and income). Again, the empirical basis of
our study does not allow conclusions on how to explain
these differences. Among other reasons, we cannot say
whether specificities of the Taiwanese compared to the
German health care system – e.g., a national health in-
surancerootinginuniversalismratherthanincorporatism
[45], and patients who tend to use (expensive) services
of (university) hospitals to the disadvantage of practices
[46] – play any role here. In sum, the question whether
differences in excess costs of severe obesity across SES
groups actually do represent instances of the inverse
care law [47] has to remain unanswered until more con-
clusive studies (possibly including supraindividual vari-
ables such as health care system parameters) are avail-
able. Such research should scrutinize routine healthcare
data in order to account for the main diagnoses and ac-
tual costs of consultations and inpatient services, and
provide empirical data on appropriate health care costs
for different levels of overweight in longitudinal designs.
Furthermore, the issue remains why in the present study
excesscostsofsevereobesityweresignificantlymediated
by comorbidities only in groups defined by a median or
below-medianvalueontheSES-Indexoralowoccupation-
al status, but not low education or low income. First of
all, the general findings that mediation was observed in
lower SES-groups only is in accordance with earlier find-
ingsindicatingthatsuchgroupsusemoreservicespartly
because they suffer from more illnesses [48]. Further-
more,besidesbeinginagreement,byscrutinizingallfour
indicators, with the assertion that the sole use of indices
to measure SES is not advisable [49], different SES-indi-
cators represent different phenomena and may tap into
different causal mechanisms [50]. In the present case,
health care services were possibly used until comorbidit-
ies were dealt with (and then stopped) by the group with
low occupational status either because there was more
pressure to return to work or because their perception of
opportunitiestoinfluencetheirownlife,includinghealth,
was lower than those with high status due to lesser work
control.However,sincecontrolofone’slifecircumstances
has been argued to be responsible for effects of all three
singleSESindicators[50](andthusdoesnottrulydiscrim-
inate between the three), compelling explanations for
differencesinmediationofexcesscostsofsevereobesity
by comorbidity across SES-indicators remain to be deter-
mined.
Conclusions
Excess costs of severe obesity in German adults are
higher in those with high SES than in those with lower
SES, regardless of whether the SES-index or single indi-
cators were used. In addition, these excess costs are
mediated by comorbidities only in those with low SES
defined either by a median or lower SES-Index, or low
occupationalstatus.Atthesametime,physicalcomorbid-
ities increase with BMI and decrease with SES, but the
factors BMI and SES did not significantly interact in this
regard. Economically, if the trend that prevalences of
severe obesity increase more steeply in groups with high
social risks [15] will continue in the future, this may re-
duce increases in health care costs driven particularly by
severe obesity. Regarding equity issues, as far as we
know the present study is the first to show in Germany
thatexcessdirectmedicalcostsofsevereobesityarenot
distributed equitably across different SES groups, do not
reflect comorbidity status, and are significantly higher in
those with high SES than in those with lower SES. Thus,
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obese adults seems to be in need of readjustment to-
wards an equitable utilization across all socioeconomic
groups [51].
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